{"id":"https://openalex.org/W155369308","doi":null,"title":"National anti-tuberculosis drug resistance survey, 2002, in Myanmar.","display_name":"National anti-tuberculosis drug resistance survey, 2002, in Myanmar.","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W155369308","mag":"155369308","pmid":"https://pubmed.ncbi.nlm.nih.gov/17044203"},"language":"en","primary_location":{"id":"pmid:17044203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17044203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035053285","display_name":"Ti Ti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405277779","display_name":"Yangon General Hospital","ror":"https://ror.org/03vyfst28","country_code":"MM","type":"healthcare","lineage":["https://openalex.org/I4405277779"]}],"countries":["MM"],"is_corresponding":false,"raw_author_name":"T Ti","raw_affiliation_strings":["National Tuberculosis Programme, Yangon General Hospital Extension Compound, Myanmar. titi@mptmail.net.mm"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tuberculosis Programme, Yangon General Hospital Extension Compound, Myanmar. titi@mptmail.net.mm","institution_ids":["https://openalex.org/I4405277779"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111388927","display_name":"Than Than Lwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Lwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071736751","display_name":"T T Mar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T T Mar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049600098","display_name":"Win Maung","orcid":"https://orcid.org/0000-0002-6536-8047","observed_orcids":["https://orcid.org/0000-0002-6536-8047"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Maung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109866477","display_name":"P Noe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Noe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075564949","display_name":"Aye Thidar Htun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Htun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111449691","display_name":"H H Kluge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H H Kluge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A Wright","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Wright","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104197019","display_name":"Mohamed Abdel Aziz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Aziz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111841190","display_name":"C N Paramasivan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C N Paramasivan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4846,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.80771746,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"10","issue":"10","first_page":"1111","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-resistant-tuberculosis","display_name":"drug-resistant tuberculosis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/multidrug-resistant-tuberculosis","display_name":"multidrug-resistant tuberculosis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/isoniazid-resistance","display_name":"isoniazid resistance","score":0.9190000295639038},{"id":"https://openalex.org/keywords/rifampicin-resistance","display_name":"rifampicin resistance","score":1.0},{"id":"https://openalex.org/keywords/pulmonary-tuberculosis","display_name":"pulmonary tuberculosis","score":0.699999988079071},{"id":"https://openalex.org/keywords/previously-treated-tuberculosis","display_name":"previously treated tuberculosis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/risk-factors-for-drug-resistance","display_name":"risk factors for drug resistance","score":0.7289999723434448},{"id":"https://openalex.org/keywords/myanmar","display_name":"Myanmar","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.937924861907959},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.8791215419769287},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.8157529830932617},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.7563868761062622},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.6284704208374023},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5518333911895752},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.42223986983299255},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.42018526792526245},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41659754514694214},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25043970346450806},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.13061419129371643},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1282646358013153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.042298585176467896}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002052","descriptor_name":"Myanmar","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004977","descriptor_name":"Ethambutol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006306","descriptor_name":"Health Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013307","descriptor_name":"Streptomycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D018088","descriptor_name":"Tuberculosis, Multidrug-Resistant","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmid:17044203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17044203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.nirt.res.in/:785","doi":null,"is_oa":false,"landing_page_url":"https://eprints.nirt.res.in//785/1/200658.pdf","pdf_url":"https://eprints.nirt.res.in//785/1/200658.pdf","source":{"id":"https://openalex.org/S4377196491","display_name":"NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210140595","host_organization_name":"National Institute of Research in Tuberculosis","host_organization_lineage":["https://openalex.org/I4210140595"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:eprints.nirt.res.in:785","doi":null,"is_oa":false,"landing_page_url":"http://eprints.nirt.res.in/785/1/200658.pdf","pdf_url":"http://eprints.nirt.res.in/785/1/200658.pdf","source":{"id":"https://openalex.org/S4377196491","display_name":"NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210140595","host_organization_name":"National Institute of Research in Tuberculosis","host_organization_lineage":["https://openalex.org/I4210140595"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"mag:155369308","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17044203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7030580582","https://openalex.org/W2132740185","https://openalex.org/W4292162831","https://openalex.org/W2414152305","https://openalex.org/W3170672986","https://openalex.org/W2256585554","https://openalex.org/W26924287","https://openalex.org/W2327664970","https://openalex.org/W2567495729","https://openalex.org/W2767078574"],"abstract_inverted_index":{"SETTING:":[0],"Thirty":[1],"townships":[2],"of":[3,10,92,121,137,148,188],"Myanmar.":[4,24],"OBJECTIVES:":[5],"To":[6],"determine":[7],"the":[8,34,38,93,110,122,146],"proportions":[9],"drug-resistant":[11],"tuberculosis":[12,20],"(TB)":[13],"in":[14,23,163],"new":[15,61,83,171],"and":[16,63,104,130,167,172],"previously":[17,66,112],"treated":[18,67,113],"pulmonary":[19],"(PTB)":[21],"cases":[22,62],"DESIGN:":[25],"A":[26],"cross-sectional":[27],"study.":[28],"Drug":[29],"susceptibility":[30,72],"was":[31,142,179],"tested":[32,70,81],"by":[33],"proportion":[35],"method":[36],"at":[37],"National":[39],"Tuberculosis":[40],"Reference":[41],"Laboratory,":[42],"Yangon.":[43],"RESULTS:":[44],"Of":[45,78,109],"874":[46],"TB":[47,84],"patients":[48,58],"included":[49],"from":[50,56,60,65,82],"30":[51],"sites,":[52],"849":[53],"isolates":[54,80],"obtained":[55],"individual":[57],"(733":[59],"116":[64,111],"cases)":[68],"were":[69,87,106,116,132],"for":[71,184],"to":[73,89,97,101,118,125,128],"four":[74],"primary":[75],"anti-tuberculosis":[76,94,135],"drugs.":[77],"733":[79],"patients,":[85,114],"10%":[86],"resistant":[88,117],"any":[90,119],"one":[91,120],"drugs,":[95,123],"6.5%":[96],"isoniazid":[98],"(INH),":[99],"4.6%":[100],"rifampicin":[102],"(RMP)":[103],"4.0%":[105],"multidrug-resistant":[107],"(MDR).":[108],"30.2%":[115],"26.7%":[124],"INH,":[126],"15.5%":[127,131,168],"RMP":[129],"MDR.":[133],"Previous":[134,176],"treatment":[136,178],"more":[138],"than":[139],"1":[140],"month":[141],"strongly":[143],"associated":[144],"with":[145],"development":[147],"MDR-TB":[149,169],"(adjusted":[150],"OR":[151],"4.8,":[152],"95%":[153],"CI":[154],"2.5-9.1).":[155],"CONCLUSION:":[156],"The":[157],"first":[158],"national":[159],"drug":[160,189],"resistance":[161,190],"survey":[162],"Myanmar":[164],"revealed":[165],"4%":[166],"among":[170],"retreatment":[173],"cases,":[174],"respectively.":[175],"antituberculosis":[177],"an":[180],"important":[181],"risk":[182],"factor":[183],"MDR-TB.":[185],"Continuous":[186],"monitoring":[187],"trends":[191],"is":[192],"needed":[193]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}